Plasma levels of DPP-4 and circulating DPP-4 activity both increase with obesity and this correlates with insulin resistance (Mulvihill and Drucker, 2014; Ahmed et al., 2017). Here, DPP4 is linked to obesity due to melanocortin 4 receptor deficiency.